Sodium-glucose cotransporter 2 inhibitors not only suppress recurrence after atrial fibrillation ablation but also cause atrial reverse remodeling

29 August 2022 (12:15 - 13:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Takanao Mine

Hyogo Medical University, Nishinomiya (Japan)

7 More presentations in this session

Presentation thumbnail

Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial

Mr A. Pandey (Hamilton, CA)

Abstract Slides

Presentation thumbnail

Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation

Doctor R. Nishinarita (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.

Doctor K. Iwakura (Osaka, JP)

Abstract Slides

Presentation thumbnail

Prognosis of atrial fibrillation with or without comorbidities. Analysis of younger adults from a nationwide database

Professor L. Fauchier (Tours, FR)

Abstract Slides

Presentation thumbnail

Influence of obesity and overweight on the association between sleep-disordered breathing and atrial fibrillation: the DASAP-HF study

Professor G. Boriani (Modena, IT)

Abstract Slides

Access the full session

Session thumbnail

Atrial fibrillation in context of concomitant medical conditions

The Event

Event poster

ESC Congress 2022

29 August 2022 12:15 CET

You may be interested in

Congress Session

Basic science and arrhythmia pathophysiology

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

How to manage atrial fibrillation in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources